arrow
G

Gilles Pernod

universite grenoble-alpes
H指数:41
被引数:6,391

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis

抗凝血因子XI(a)患者在出血和侵入性操作中的管理:法国围手术期止血工作组及法国血栓与止血学会的建议

2025-03-010
OAAI
Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence

静脉血栓栓塞症的延长治疗:高风险复发患者中减量与标准剂量直接口服抗凝剂的应用比较

BLOOD
IF23.1
2024-11-250
PRE
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network

围术期静脉血栓栓塞症的预防:法国围术期止血工作组(GIHP)2024年指南,由其与法国麻醉与重症医学学会(SFAR)、法国血栓与止血学会(SFTH)和法国血管医学学会(SFMV)合作制定,并得到法国消化外科学会(SFCD)、法国药理学与治疗学学会(SFPT)以及INNOVTE(静脉血栓栓塞症研究网络)的支持。

2024-10-220
OAAI
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial
2024-01-012
PRE
Outpatient management of cancer-related pulmonary embolism: a post-hoc analysis of the HOME-PE trial
2023-10-272
PRE
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies

首次非诱因性肺栓塞后慢性血栓栓塞性肺动脉高压的频率和预测因素: PADIS研究的结果

2022-12-017
OAAI
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)

根据肺部疾病程度调整D-二聚体排除新型冠状病毒肺炎患者肺栓塞 (共同导联)

2022-10-177
OAAI
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
2022-07-017
OAAI
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism A Randomized Trial
CHEST
IF8.6
2022-03-0196
PRE
Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies
2021-11-250
PRE
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
2021-08-0774
OAAI
Comparison of the Use of Arterial Doppler Waveform Classifications in Clinical Routine to Describe Lower Limb Flow
2021-01-265
OAAI
Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism
2019-07-0118
OAAI
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial

无缘无故肺栓塞后残余肺血管阻塞的预测因素: 对临床实践的影响-PADIS-PE试验

2019-06-2317
PREAI